Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories International Inc. (CRL) shares rose 4.84% to $229.29, outperforming competitors like Labcorp and Alnylam during a broader market decline. This gain ended a four-day losing streak, though the stock remains below its 52-week high. Trading volume exceeded the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) rose 4.84% to $229.29 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
The stock's rise snapped a four-day losing streak.
Charles River Laboratories International Inc. closed 3.60% below its 52-week high of $237.86, which the company achieved on July 10th.
The stock outperformed some of its competitors Thursday, as Labcorp Holdings Inc. (LH) rose 3.40% to $291.02, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.66% to $268.74, and Bio-Techne Corp. (TECH) fell 0.01% to $71.77.
Trading volume (1.1 M) eclipsed its 50-day average volume of 888,225.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-23-26 1716ET